IBIRONKE OTETUBI: Open Payments
NPI 1730773656 · MORRIS PLAINS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 33 payments from 9 companies in 2025. Trend: 2023 $911 · 2024 $592 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $144 |
| Alkermes, Inc. | 7 | $136 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Lundbeck LLC | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, ARISTADA, COBENFY, REXULTI, AUSTEDO XR, CAPLYTA, INVEGA SUSTENNA, Auvelity.
Industry payments across NJ — which companies pay providers there.
